1. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?
- Author
-
Kristine Løssl, Mie Stougaard Kroman, Hanne Frederiksen, Kathrine Birch Petersen, Henriette Svarre Nielsen, Selma Kloeve Landersoe, Anders Juul, E.C. Larsen, Bugge Nøhr, Julie Lyng Forman, and Anders Nyboe Andersen
- Subjects
Adult ,Anti-Mullerian Hormone ,endocrine system ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,Physiology ,Degree (temperature) ,Endocrinology ,Ovarian Follicle ,Ovarian suppression ,Medicine ,Endocrine system ,Humans ,Ovarian reserve ,Ovarian Reserve ,Estradiol ,business.industry ,Combined oral contraceptives ,Age Factors ,Obstetrics and Gynecology ,respiratory system ,Luteinizing Hormone ,Antral follicle ,female genital diseases and pregnancy complications ,Contraceptives, Oral, Combined ,Cross-Sectional Studies ,Androgens ,Female ,Follicle Stimulating Hormone ,business ,Oral contraception ,Hormone - Abstract
The ovarian reserve markers anti-Müllerian hormone (AMH) and antral follicle count (AFC) are suppressed in varying degree during the use of combined oral contraceptives (COC). Further, long-term use of COC can mask a condition of premature ovarian insufficiency. A desirable clinical tool that could distinguish true low ovarian reserve markers from COC-induced low levels
- Published
- 2020